430 related articles for article (PubMed ID: 27651238)
1. RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2.
Zou Q; Wu H; Fu F; Yi W; Pei L; Zhou M
Arch Biochem Biophys; 2016 Nov; 610():25-32. PubMed ID: 27651238
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of RKIP inhibits cell invasion in glioma cell lines through upregulation of miR-98.
Chen Z; Cheng Q; Ma Z; Xi H; Peng R; Jiang B
Biomed Res Int; 2013; 2013():695179. PubMed ID: 24392454
[TBL] [Abstract][Full Text] [Related]
3. RKIP and HMGA2 regulate breast tumor survival and metastasis through lysyl oxidase and syndecan-2.
Sun M; Gomes S; Chen P; Frankenberger CA; Sankarasharma D; Chung CH; Chada KK; Rosner MR
Oncogene; 2014 Jul; 33(27):3528-37. PubMed ID: 23975428
[TBL] [Abstract][Full Text] [Related]
4. Raf kinase inhibitor protein (RKIP) inhibits the cell migration and invasion in human glioma cell lines in vitro.
Lei X; Chang L; Ye W; Jiang C; Zhang Z
Int J Clin Exp Pathol; 2015; 8(11):14214-20. PubMed ID: 26823735
[TBL] [Abstract][Full Text] [Related]
5. MiR-543 Promotes Proliferation and Epithelial-Mesenchymal Transition in Prostate Cancer via Targeting RKIP.
Du Y; Liu XH; Zhu HC; Wang L; Ning JZ; Xiao CC
Cell Physiol Biochem; 2017; 41(3):1135-1146. PubMed ID: 28245474
[TBL] [Abstract][Full Text] [Related]
6. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer.
Ren G; Baritaki S; Marathe H; Feng J; Park S; Beach S; Bazeley PS; Beshir AB; Fenteany G; Mehra R; Daignault S; Al-Mulla F; Keller E; Bonavida B; de la Serna I; Yeung KC
Cancer Res; 2012 Jun; 72(12):3091-104. PubMed ID: 22505648
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells.
Huang L; Dai T; Lin X; Zhao X; Chen X; Wang C; Li X; Shen H; Wang X
Biochem Biophys Res Commun; 2012 Aug; 425(2):127-33. PubMed ID: 22809510
[TBL] [Abstract][Full Text] [Related]
8. MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2.
Xing F; Song Z; He Y
Biol Res; 2018 Nov; 51(1):50. PubMed ID: 30474570
[TBL] [Abstract][Full Text] [Related]
9. Cordycepin (3'-deoxyadenosine) suppressed HMGA2, Twist1 and ZEB1-dependent melanoma invasion and metastasis by targeting miR-33b.
Zhang P; Huang C; Fu C; Tian Y; Hu Y; Wang B; Strasner A; Song Y; Song E
Oncotarget; 2015; 6(12):9834-53. PubMed ID: 25868853
[TBL] [Abstract][Full Text] [Related]
10. The lncRNA NEAT1 facilitates cell growth and invasion via the miR-211/HMGA2 axis in breast cancer.
Li X; Wang S; Li Z; Long X; Guo Z; Zhang G; Zu J; Chen Y; Wen L
Int J Biol Macromol; 2017 Dec; 105(Pt 1):346-353. PubMed ID: 28720546
[TBL] [Abstract][Full Text] [Related]
11. Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages.
Frankenberger C; Rabe D; Bainer R; Sankarasharma D; Chada K; Krausz T; Gilad Y; Becker L; Rosner MR
Cancer Res; 2015 Oct; 75(19):4063-73. PubMed ID: 26238785
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
[TBL] [Abstract][Full Text] [Related]
13. RKIP Inhibits Local Breast Cancer Invasion by Antagonizing the Transcriptional Activation of MMP13.
Datar I; Feng J; Qiu X; Lewandowski J; Yeung M; Ren G; Aras S; Al-Mulla F; Cui H; Trumbly R; Arudra SK; De Las Casas LE; de la Serna I; Bitar MS; Yeung KC
PLoS One; 2015; 10(8):e0134494. PubMed ID: 26308852
[TBL] [Abstract][Full Text] [Related]
14. RKIP inhibits gastric cancer cell survival and invasion by regulating the expression of HMGA2 and OPN.
Liu H; Li P; Li B; Sun P; Zhang J; Wang B; Jia B
Tumour Biol; 2014 Dec; 35(12):11949-58. PubMed ID: 25172097
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells.
Wang X; Li Y; Qi W; Zhang N; Sun M; Huo Q; Cai C; Lv S; Yang Q
Oncotarget; 2015 Oct; 6(32):32737-47. PubMed ID: 26417931
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
17. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
[TBL] [Abstract][Full Text] [Related]
18. miR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2.
Huang W; Li J; Guo X; Zhao Y; Yuan X
Biomed Pharmacother; 2016 Jul; 81():431-438. PubMed ID: 27261623
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of miR-194 Reverses HMGA2-driven Signatures in Colorectal Cancer.
Chang HY; Ye SP; Pan SL; Kuo TT; Liu BC; Chen YL; Huang TC
Theranostics; 2017; 7(16):3889-3900. PubMed ID: 29109785
[TBL] [Abstract][Full Text] [Related]
20. Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer.
Li Y; Tian Z; Tan Y; Lian G; Chen S; Chen S; Li J; Li X; Huang K; Chen Y
Mol Cancer; 2020 Jun; 19(1):109. PubMed ID: 32580736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
